Turn Therapeutics
$10.43
5
-$0.29-2.71%Friday 20:00
+$0.22+2.11%Friday 21:33After hours
Statistics
Day High
10.51
Day Low
10.43
52W High
16.45
52W Low
2.57
Volume
12,094
Avg. Volume
-
Mkt Cap
316.74M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 12Expected
Q3 2025
Q1 2026
Q2 2026
Next
-0.2
-0.14
-0.08
-0.02
Expected EPS
-0.086667
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-6.82MNet Income
Analyst Ratings
$17.00Average Price Target
The highest estimate is 24.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.
Show More
CEO
Bradley E. Burnam
Employees
2
Country
United States
ISIN
US90021W1053
Listings
0 Comments
Share your thoughts
FAQs
What is Turn Therapeutics stock price today?▼
The current price of TTRX is $10.43 USD — it has decreased by -2.71% in the past 24 hours. Watch Turn Therapeutics stock price performance more closely on the chart.
What is Turn Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Turn Therapeutics stocks are traded under the ticker TTRX.
Is Turn Therapeutics stock price growing?▼
TTRX stock has fallen by -1.7% compared to the previous week, the month change is a -21.76% fall, over the last year Turn Therapeutics has showed a +115.05% increase.
What is Turn Therapeutics market cap?▼
Today Turn Therapeutics has the market capitalization of 316.74M
When is the next Turn Therapeutics earnings date?▼
Turn Therapeutics is going to release the next earnings report on November 12, 2026.
What were Turn Therapeutics earnings last quarter?▼
TTRX earnings for the last quarter are -0.2 USD per share, whereas the estimation was -0.02 USD resulting in a -900% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Turn Therapeutics revenue for the last year?▼
Turn Therapeutics revenue for the last year amounts to 0 USD.
What is Turn Therapeutics net income for the last year?▼
TTRX net income for the last year is -6.82M USD.
How many employees does Turn Therapeutics have?▼
As of November 2, 2026, the company has 2 employees.
In which sector is Turn Therapeutics located?▼
Turn Therapeutics operates in the Health & Wellness sector.
When did Turn Therapeutics complete a stock split?▼
Turn Therapeutics has not had any recent stock splits.
Where is Turn Therapeutics headquartered?▼
Turn Therapeutics is headquartered in WESTLAKE VILLAGE, United States.